Showing results (1291-1300 of 1,495) with videos related to

Sort By:
Pageof 150
Bone Marrow Transplantation|August 6, 2003
ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML)A R Zander, N Kröger, M Schleuning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2015
Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or LymphomaJatin J Shah, Andrzej J Jakubowiak, Owen A O'Connor, et al.
Plos One|December 29, 2015
KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor MetabolismNibedita Chattopadhyay, Allison J Berger, Erik Koenig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2015
Phase I Study of the Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients with Advanced Solid TumorsJohn Sarantopoulos, Geoffrey I Shapiro, Roger B Cohen, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Paenilamicins from the honey bee pathogen <i>Paenibacillus larvae</i> are context-specific translocation inhibitors of protein synthesisTimm O Koller, Max J Berger, Martino Morici, et al.
Journal of Neuroengineering and Rehabilitation|May 19, 2026
Non-invasive spinal cord neuromodulation enables volitional anti-gravity leg movements after motor-complete spinal cord injury: responders vs. non-respondersRaza N Malik, Soshi Samejima, Alison M M Williams, et al.
Nature Chemical Biology|October 17, 2024
Paenilamicins are context-specific translocation inhibitors of protein synthesisTimm O Koller, Max J Berger, Martino Morici, et al.
Blood Cancer Journal|December 3, 2013
(18)F-FDG-PET/CT imaging in an IL-6- and MYC-driven mouse model of human multiple myeloma affords objective evaluation of plasma cell tumor progression and therapeutic response to the proteasome inhibitor ixazomibK Duncan, T R Rosean, V S Tompkins, et al.
Transfusion|June 23, 2025
Factors associated with active syphilis infection in US blood donorsVivian I Avelino-Silva, Roberta L Bruhn, Zhanna Kaidarova, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 6, 1998
Tuberculosis among foreign-born persons in New York City, 1992-1994: implications for tuberculosis controlN G Tornieporth, Y Ptachewich, N Poltoratskaia, et al.
Pageof 150